Questions About Brazil? We can help.

We have completed 425+ Brazil consulting projects.

Brazil Medical Device Regulatory Strategy Report

Brazil is the largest market for medical devices in Latin America, attracting major attention from foreign manufacturers. The National Health Surveillance Agency Brazil (ANVISA) regulates Brazil’s medical device market, and all manufacturers must register their products with the agency prior to commercialization in Brazil.

ANVISA has established essential requirements for compliance similar to those developed in the European Union, and provides two major pathways to device approval: Cadastro (low risk) and Registro (high risk). Cadastro is simpler and faster, but both Cadastro and Registro require formal registration and approval from ANVISA.

Emergo can help you determine which of the above processes your device will fall under, as well as any additional requirements that will apply to your device. Additionally, we confirm the overall costs and timeline to market, so that you can pre-assess the requirements.

Let Emergo assist you in evaluating the Brazilian medical device regulatory framework as it applies to your device(s)

Emergo's Global Regulatory Overview Reports draw upon our worldwide network of consultants, industry resources and regulatory contacts in order to provide you with in-depth and accurate analysis on the medical device market in Brazil. Our Brazilian country report coverage includes:

ANVISA Regulatory Background

Product Assessment based on Brazilian Requirements

Device Classification based on ANVISA Criteria

Additional regulations which apply to your device

In-Country Representation in Brazil

Registro and/or Cadastro Registration requirements

Medical Device Labeling Requirements

Costs and Timeframes

Regulatory Roadmap

Post-market Surveillance Requirements

Please contact us for more information about our Regulatory Overview Report for Brazil.

Ask us for detailed information about Brazil regulatory strategy services.

Within the UL family of companies we provide a broad portfolio of offerings to all the medical device industries. This includes certification, Notified Body and consultancy services. In order to protect and prevent any conflict of interest, perception of conflict of interest and protection of both our brand and our customers brands, UL is unable to provide consultancy services to Notified Body or MDSAP customers. UL has processes in place to identify and manage any potential conflicts of interest and maintain impartiality. Learn more here.